The American journal of cardiology
Authors: Lee TC, Qian M, Lip GYH, Di Tullio MR, Graham S, Mann DL, Nakanishi K, Teerlink JR, Freudenberger RS, Sacco RL, Mohr JP, Labovitz AJ, Ponikowski P, Lok DJ, Estol C, Anker SD, Pullicino PM, Buchsbaum R, Levin B, Thompson JLP, Homma S, Ye S
Nature medicine
Authors: McDermott DF, Huseni MA, Atkins MB, Motzer RJ, Rini BI, Escudier B, Fong L, Joseph RW, Pal SK, Reeves JA, Sznol M, Hainsworth J, Rathmell WK, Stadler WM, Hutson T, Gore ME, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri TK, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen DS, Hegde PS, Schiff C, Fine GD, Powles T
International journal of epidemiology
Authors: Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Authors: Arinaitwe E, Dorsey G, Nankabirwa JI, Kigozi SP, Katureebe A, Kakande E, Rek J, Rosenthal PJ, Drakeley C, Kamya MR, Staedke SG
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Authors: Fitzpatrick J, Sozio SM, Jaar BG, Estrella MM, Segev DL, Parekh RS, McAdams-DeMarco MA
Thrombosis and haemostasis
Authors: Viola JR, Lemnitzer P, Paulin N, Drechsler M, Nazari-Jahantigh M, Maas S, De Jong RJ, Winter J, Schober A, Weber C, Atabai K, Soehnlein O
The Journal of infectious diseases
Authors: Lidofsky A, Holmes JA, Feeney ER, Kruger AJ, Salloum S, Zheng H, Seguin IS, Altinbas A, Masia R, Corey KE, Gustafson JL, Schaefer EA, Hunt PW, Deeks S, Somsouk M, Chew KW, Chung RT, Alatrakchi N
Volume 53 of Issue 5 | Health services research
Authors: Yoon J, Chee CP, Su P, Almenoff P, Zulman DM, Wagner TH
OBJECTIVES
To examine high-cost patients in VA and factors associated with persistence in high costs over time.
DATA SOURCES
Secondary data for FY2008-2012.
DATA EXTRACTION
We obtained VA and Medicare utilization and cost records for VA enrollees and drew a 20 percent random sample (N = 1,028,568).
STUDY DESIGN
We identified high-cost patients, defined as those in the top 10 percent of combined VA and Medicare costs, and determined the number of years they remained high cost over 4 years. We compared sociodemographics, clinical characteristics, and baseline utilization by number of high-cost years and conducted a discrete time survival analysis to predict high-cost persistence.
PRINCIPAL FINDINGS
Among 105,703 patients with the highest 10 percent of costs at baseline, 68 percent did not remain high cost in subsequent years, 32 percent had high costs after 1 year, and 7 percent had high costs in all four follow-up years. Mortality, which was 47 percent by end of follow-up, largely explained low persistence. The largest percentage of patients who persisted as high cost until end of follow-up was for spinal cord injury (16 percent).
CONCLUSION
Most high-cost patients did not remain high cost in subsequent years, which poses challenges to providers and payers to manage utilization of these patients.
View on PubMed
The American journal of cardiology
Authors: Guo X, Hayward RM, Vittinghoff E, Liu Y, Lee SY, Pletcher MJ, Lee BK
Heart rhythm
Authors: Scheinman MM
